Liquidmetal Technologies Inc (LQMT)

[Researchfyi]

Absolutely correct…

https://www.prnewswire.com/news-releases/movano-health-submits-exemplary-sp02-clinical-trial-results-in-key-step-towards-fda-510k-clearance-decision-302140861.html

The sp02 imo, is not a big deal. Blood pressure would be, as it would capture every one’s interest from any gender. The blood oxygen is a big deal for anyone with a pulmonary issue or contracting flu like symptoms. During a pandemic it would be a serious helpful aid.

Other than people who have pulmonary issues with blood oxygen saturation, I don’t think right now is the reason to go out and buy this product.

The blood pressure measurement would be huge. According to MOVANO, they are years away from that achievement. Presently I can see the application being successful for women if the data is accurate.

I’m sure your comments come from personal experience and movano’s own admission of not being ready to roll out much larger demand. Looks like they have the resources to get their act together long term. But as for now their stock price is in the crapper.